The Technical AnalystExchange: HKSE Sector: Consumer products Industry: Drug Manufacturers—Specialty & Generic
Zhongzhi Pharmaceutical Price, Forecast, Insider, Ratings, Fundamentals & Signals
1.69% HKD1.200
America/New_York / 3 mai 2024 @ 02:59
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 1 016.40 mill |
| EPS: | 0.210 |
| P/E: | 5.71 |
| Earnings Date: | Mar 22, 2024 |
| SharesOutstanding: | 847.00 mill |
| Avg Daily Volume: | 0.776 mill |
| RATING 2024-05-02 |
|---|
| A |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Buy | |
| Return On Asset: | Buy | |
| DE: | Buy | |
| P/E: | Neutral | |
| Price To Book: | Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/21 | 4/21 | 2/22 | 4/22 | 2/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.37x |
| Company: PE 5.71 | sector: PE 15.57 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.44x |
| Company: PE 5.71 | industry: PE 13.09 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
HKD2.21 (84.09%) HKD1.009 |
| Date: 2024-05-03 |
| Expected Trading Range (DAY) |
|---|
|
HKD 1.132 - 1.268 ( +/- 5.67%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 |
| Volume Signals | |
|---|---|
| Price | HKD1.200 (1.69% ) |
| Volume | 0.0560 mill |
| Avg. Vol. | 0.776 mill |
| % of Avg. Vol | 7.22 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For 3737.HK
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
3737.HK
Zhongzhi Pharmaceutical Holdings Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People's Republic of China. The company operates through three segments: Pharmaceutical Manufacturing, Operation of Chain Pharmacies, and Operation of On-Line Pharmacies. It provides Chinese patent medicines and decoction pieces under the Zeus, Liumian, and Caojinghua brands. The company is also manufacture and sale of food and Chinese herbs; property management; and pharmaceutical drugs, as well as offers detection and testing services. As of December 31, 2021, it operated 398 self-operated chain pharmacies, including 361 medical insurance designated pharmacies located in Zhongshan in the Guangdong Province under the Zeus brand. The company was founded in 1993 and is headquartered in Zhongshan, the People's Republic of China. Zhongzhi Pharmaceutical Holdings Limited is a subsidiary of Crystal Talent Investment Group Limited.